Age-Related Changes in Axonal and Mitochondrial Ultrastructure and Function in White Matter.
The impact of aging on CNS white matter (WM) is of general interest because the global effects of aging on myelinated nerve fibers are more complex and profound than those in cortical gray matter. It is important to distinguish between axonal changes created by normal aging and those caused by neurodegenerative diseases, including multiple sclerosis, stroke, glaucoma, Alzheimer's disease, and traumatic brain injury. Using three-dimensional electron microscopy, we show that in mouse optic nerve, which is a pure and fully myelinated WM tract, aging axons are larger, have thicker myelin, and are characterized by longer and thicker mitochondria, which are associated with altered levels of mitochondrial shaping proteins. These structural alterations in aging mitochondria correlate with lower ATP levels and increased generation of nitric oxide, protein nitration, and lipid peroxidation. Moreover, mitochondria-smooth endoplasmic reticulum interactions are compromised due to decreased associations and decreased levels of calnexin and calreticulin, suggesting a disruption in Ca(2+) homeostasis and defective unfolded protein responses in aging axons. Despite these age-related modifications, axon function is sustained in aging WM, which suggests that age-dependent changes do not lead to irreversible functional decline under normal conditions, as is observed in neurodegenerative diseases.



Aging is a common risk factor for a number of neurodegenerative diseases, including stroke. Mitochondrial dysfunction and oxidative damage with age are hypothesized to increase risk for stroke. We compared axon-myelin-node-mitochondrion-smooth endoplasmic reticulum (SER) interactions in white matter obtained at 1 and 12 months. We show that aging axons have enlarged volume, thicker myelin, and elongated and thicker mitochondria. Furthermore, there are reduced SER connections to mitochondria that correlate with lower calnexin and calreticulin levels. Despite a prominent decrease in number, elongated aging mitochondria produce excessive stress markers with reduced ATP production. Because axons maintain function under these conditions, our study suggests that it is important to understand the process of normal brain aging to identify neurodegenerative changes.
Department of Neurosciences, Cleveland Clinic Foundation, Cleveland, Ohio 44195.
Katharine E
KE
Stahon
Department of Neurosciences, Cleveland Clinic Foundation, Cleveland, Ohio 44195.
Chinthasagar
0000-0001-5759-5496
C
Bastian
Department of Neurosciences, Cleveland Clinic Foundation, Cleveland, Ohio 44195.
Shelby
S
Griffith
Department of Neurosciences, Cleveland Clinic Foundation, Cleveland, Ohio 44195.
Grahame J
GJ
Kidd
Department of Neurosciences, Cleveland Clinic Foundation, Cleveland, Ohio 44195.
Sylvain
0000-0002-7506-9585
S
Brunet
Department of Neurosciences, Cleveland Clinic Foundation, Cleveland, Ohio 44195 baltans@ccf.org.
Selva
0000-0003-1123-3582
S
Baltan
D000375:Aging / Q000473:pathology* / Q000502:physiology; D000818:Animals; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008928:Mitochondria / Q000502:physiology / Q000648:ultrastructure*; D009900:Optic Nerve / Q000502:physiology / Q000648:ultrastructure*; D013329:Structure-Activity Relationship; D066127:White Matter / Q000502:physiology / Q000648:ultrastructure*
aging; axon; mitochondrial dynamic; myelin; neurodegeneration; three-dimensional electron microscopy
J Neurosci. 2009 Mar 4;29(9):2824-32
19261878
Trends Biochem Sci. 2001 Jan;26(1):23-9
11165513
J Neurosci. 2010 Apr 21;30(16):5644-52
20410117
Biochim Biophys Acta. 2009 Nov;1787(11):1324-33
19366607
J Biol Chem. 2005 Jul 1;280(26):25060-70
15878861
Science. 2011 Feb 4;331(6017):599-601
21292979
Curr Aging Sci. 2011 Jul;4(2):110-7
21235491
J Microsc. 2005 Apr;218(Pt 1):52-61
15817063
J Comp Neurol. 2002 Mar 25;445(1):13-28
11891651
Dev Cell. 2001 Oct;1(4):515-25
11703942
J Biol Chem. 2007 Aug 17;282(33):23788-98
17537722
J Biosci. 2003 Jun;28(4):379-82
12799486
Neuropharmacology. 2016 Nov;110(Pt B):626-632
26407763
J Comp Neurol. 2010 Aug 1;518(15):3046-64
20533359
Neuron. 2001 Apr;30(1):91-104
11343647
J Biol Chem. 2003 Mar 7;278(10):7743-6
12509422
Aging Cell. 2009 Apr;8(2):201-13
19338498
Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):15927-32
15509649
Ann Neurol. 1991 Sep;30(3):375-80
1952825
J Comp Neurol. 2006 Apr 1;495(4):351-62
16485288
Nat Rev Mol Cell Biol. 2010 Dec;11(12):872-84
21102612
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8168-73
15148385
Neuron. 2001 Apr;30(1):105-19
11343648
J Am Med Inform Assoc. 2001 Jan-Feb;8(1):1-16
11141509
Nat Methods. 2012 Jun 28;9(7):676-82
22743772
Front Neuroanat. 2009 Jul 06;3:11
19636385
J Neurocytol. 1998 Aug;27(8):605-14
10405027
J Neurosci. 2011 Mar 16;31(11):3990-9
21411642
EMBO J. 2009 Jun 3;28(11):1589-600
19360003
Nat Methods. 2007 Jul;4(7):559-61
17558414
Brain Res. 1982 Mar;255(3):371-86
7066695
Neuroscientist. 2009 Apr;15(2):126-33
19307420
Glia. 2012 Apr;60(4):651-60
22290828
Nature. 2008 Dec 4;456(7222):605-10
19052620
J Neurosci. 2003 May 1;23(9):3807-19
12736351
Neurochem Res. 2017 Jan;42(1):19-34
26915104
Physiology (Bethesda). 2008 Apr;23:84-94
18400691
Science. 2011 Oct 21;334(6054):358-62
21885730
Brain Res Mol Brain Res. 2002 Sep 30;105(1-2):19-28
12399104
J Neurochem. 2014 May;129(3):509-15
24147654
J Neurosci. 2008 Feb 6;28(6):1479-89
18256269
Anat Histol Embryol. 2003 Feb;32(1):12-6
12733267
J Biol Chem. 2005 Jul 15;280(28):26185-92
15899901
Gen Physiol Biophys. 2009;28 Spec No Focus:F96-F103
20093733
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13807-12
10570154
J Neurochem. 2012 Nov;123 Suppl 2:108-15
23050648
J Comp Neurol. 2000 Apr 10;419(3):364-76
10723011
Pflugers Arch. 2007 Dec;455(3):375-96
17611770
Electroencephalogr Clin Neurophysiol. 1979 Jun;46(6):634-46
87308
Nature. 2004 Jan 22;427(6972):360-4
14737170
Can J Ophthalmol. 2002 Dec;37(7):389-94
12516719
J Physiol. 1949 Mar 1;108(1):37-77
18128147